Hybrid Conferencee

International Conference on Neuroscience and Neurodegenerative Biomarkers (ICNNB - 26)

30th - 1st December 2026 | Dallas, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Dallas. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Dallas event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Dallas conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Dallas, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Dallas."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Alzheimer's Research

This track focuses on the latest findings in Alzheimer's disease research, emphasizing novel therapeutic approaches and interventions. Participants will explore cutting-edge studies that highlight the role of biomarkers in early diagnosis and treatment efficacy.

Track 02

Neurodegenerative Disease Mechanisms

This session will delve into the underlying biological mechanisms that contribute to neurodegenerative diseases. Discussions will include genetic, environmental, and lifestyle factors that influence disease progression.

Track 03

Biomarkers in Neurodegeneration

This track aims to present recent advancements in the identification and validation of biomarkers for neurodegenerative diseases. Researchers will share insights on how these biomarkers can enhance diagnostic accuracy and patient stratification.

Track 04

Neuroinflammation and Neurodegeneration

This session will explore the relationship between neuroinflammation and the progression of neurodegenerative disorders. Presentations will focus on the role of inflammatory pathways and potential therapeutic targets.

Track 05

Cognitive Decline and Biomarker Correlation

This track will investigate the correlation between cognitive decline and various neurodegenerative biomarkers. Researchers will present data on how these biomarkers can predict cognitive impairment and disease trajectory.

Track 06

Neuroimaging Techniques in Biomarker Discovery

This session will highlight the role of advanced neuroimaging techniques in the discovery and validation of neurodegenerative biomarkers. Participants will discuss the integration of imaging data with clinical outcomes.

Track 07

Translational Research in Neuroscience

This track will focus on the translation of basic neuroscience research into clinical applications for neurodegenerative diseases. Emphasis will be placed on collaborative efforts between researchers and clinicians.

Track 08

Psychosocial Factors in Neurodegenerative Diseases

This session will examine the psychosocial factors that influence the experience and management of neurodegenerative diseases. Discussions will include the impact of mental health on disease progression and patient outcomes.

Track 09

Innovative Therapeutics for Neurodegeneration

This track will showcase innovative therapeutic strategies being developed for the treatment of neurodegenerative diseases. Presentations will cover pharmacological and non-pharmacological interventions.

Track 10

Patient-Centered Approaches in Neuroscience

This session will focus on the importance of patient-centered approaches in the management of neurodegenerative diseases. Researchers will discuss strategies for involving patients in research and treatment decision-making.

Track 11

Future Directions in Neurodegenerative Biomarkers

This track will explore future directions and emerging trends in the field of neurodegenerative biomarkers. Participants will engage in discussions about the potential for personalized medicine and novel diagnostic tools.